Published Online
on August 2, 2007

A more recent version of this article appeared on September 1, 2007

This Article Full Text (PDF) All Versions of this Article: 38/9/2413    most recent STROKEAHA.107.488361v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Arboix, A. Search for Related Content PubMed PubMed Citation Articles by Arboix, A. Pubmed/NCBI databases Medline Plus Health Information Diabetes Stroke Related Collections Type 2 diabetes Other Treatment Acute Cerebral Infarction Neuroprotectors Related Article

Potential Impact of Sulfonylureas in the Outcome of Type 2 Diabetic Patients With Ischemic Stroke

Adrià Arboix MD, PhD^*

From the Cerebrovascular Division, Department of Neurology, Hospital Universitari del Sagrat Cor, Universitat de Barcelona, Barcelona, Spain.

^* To whom correspondence should be addressed. E-mail: aarboix{at}hscor.com.

Key words: cerebral infarction • diabetes mellitus • type 2 • stroke management • stroke outcome • sulfonylurea compounds

Related Article:

Sulfonylureas Improve Outcome in Patients With Type 2 Diabetes and Acute Ischemic Stroke

Hagen Kunte, Sein Schmidt, Michael Eliasziw, Gregory J. del Zoppo, J. Marc Simard, Florian Masuhr, Markus Weih, and Ulrich Dirnagl
Stroke 2007 38: 2526-2530. [Abstract] [Full Text] [PDF]